Back in 2011 when we ran a poll about research in the NHS, 72% of people stated that they would like to be given the chance to participate in clinical trials. Unfortunately, the number of people actually given this opportunity is much lower. Target Ovarian Cancer recently discovered that only 7% of the 7000 women diagnosed with ovarian cancer each year enter a clinical trial, with the location of patients all to often playing a deciding factor in access to clinical trials.
In an effort to increase clinical trials participation amongst ovarian cancer sufferers, Target Ovarian Cancer has released a Clinical Trials Manifesto. As well as outlining what needs to change to improve access to trials, the manifesto explains what they are doing to improve the situation for ovarian cancer patients. This includes:
- Giving patients and health professionals information on current ovarian cancer trials through its Clinical Trials Information Centre.
- Funding two clinical trials into ovarian cancer which will recruit over 500 UK patients.
- Working with the Department of Health, National Cancer Research Network and the National Cancer Research Institute to improve the current process.